Table 1 Clinical characteristics by genotype the of PCD patients that provided cell samples for the study.

From: Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia

 

DNAH5

CCDC39

DNAH11

WT1

WT2

Mutation

c.10815del

c.13309del

c.357 + 1G > C

c.357 + 1G > C

c.7904_7914 + 643del

c.7904_7914 + 643del

N/A

N/A

Age at sample

3 years

18 years

6 months

40 years

52 years

Age at diagnosis

2 years

13 years

6 months

N/A

N/A

Infection present at time of collection

No

No

No

No

No

Treatment with azithromycin

No

No

No

No

No

Treatment with corticosteroids

Inhaled yes

No

No

No

No

FEV1 at diagnosis

NA

80%-pred

NA

100%-pred

102%-pred